nach oben

Inflammation

Erschienen in:

01.07.2022 | Original Article

Bifidobacterium bifidum and Bacteroides fragilis Induced Differential Immune Regulation of Enteric Glial Cells Subjected to Exogenous Inflammatory Stimulation

verfasst von: Yan-hua Yang, Wei Qian, Xiao-hua Hou, Chi-bing Dai

Erschienen in: Inflammation | Ausgabe 6/2022

Einloggen, um Zugang zu erhalten

Abstract

Enteric glial cells (EGCs) are involved in intestinal inflammation. In this study, we will investigate how Bifidobacterium bifidum (B.b.) and Bacteroides fragilis (B.f.) influence EGC regulation. After pretreatment with lipopolysaccharide (LPS) and interferon-γ (IFN-γ), the expressions of major histocompatibility complex class II (MHC-II), CD80, CD86, glial cell line-derived neurotrophic factor (GDNF), toll-like receptor 2 (TLR-2), and tumor necrosis factor-α (TNF-α) in EGCs were detected using polymerase chain reaction and western blot after co-culture with the supernatants of B.b. or B.f. (multiplicity of infection, 40:1 or 80:1). Finally, EGCs were co-cultured with naive CD₄⁺ T cells, and the expressions of interleukin (IL)-2, IL-4, IL-10, and IL-17 in supernatant were measured using enzyme-linked immunosorbent assay (ELISA). The mRNA expressions of MHC-II and CD86 in EGCs were increased after combined stimulation with LPS and IFN-γ. The expressions of MHC-II, GDNF, TLR-2, and TNF-α were all significantly upregulated in stimulated EGCs. The B.b. supernatant downregulated the expressions of MHC-II, GDNF, TLR-2, and TNF-α in stimulated EGCs, whereas the B.f. supernatant upregulated TLR-2 expression and downregulated MHC-II expression. The expressions of IL-4, IL-2, and IL-17 after co-culture of naive CD₄⁺ T cells and stimulated EGCs were significantly increased. The supernatant of B.b. or B.f. downregulated the expressions of these cytokines. The low-concentration B.b. supernatant upregulated IL-10 expression. Conclusions B.b. and B.f. may influence intestinal inflammation by regulating MHC-II, GDNF, TLR-2, and TNF-α expression in EGCs and IL-4, IL-2, IL-17, and IL-10 secretion.

Hadjivasilis, A., C. Tsioutis, A. Michalinos, D. Ntourakis, D.K. Christodoulou, and A.P. Agouridis. 2019. New insights into irritable bowel syndrome: From pathophysiology to treatment. Annals of Gastroenterology 32 (6): 554–564. https://doi.org/10.20524/aog.2019.0428.CrossRefPubMedPubMedCentral

Rusu, F., L. Mocanu, and D.L. Dumitrascu. 2019. Phenotypic features of patients with post-infectious irritable bowel syndrome. Med Pharm Rep 92 (3): 239–245. https://doi.org/10.15386/mpr-1317.CrossRefPubMedPubMedCentral

Sundin, J., I. Rangel, A.K. Kumawat, E. Hultgren-Hornquist, and R.J. Brummer. 2014. Aberrant mucosal lymphocyte number and subsets in the colon of post-infectious irritable bowel syndrome patients. Scandinavian Journal of Gastroenterology 49 (9): 1068–1075. https://doi.org/10.3109/00365521.2014.926982.CrossRefPubMed

Du, L., Y. Long, J.J. Kim, B. Chen, Y. Zhu, and N. Dai. 2019. Protease activated receptor-2 induces immune activation and visceral hypersensitivity in post-infectious irritable bowel syndrome mice. Digestive Diseases and Sciences 64 (3): 729–739.CrossRefPubMed

Boesmans, W., M.M. Hao, C. Fung, Z. Li, C. Van den Haute, J. Tack, V. Pachnis, and P. Vanden Berghe. 2019. Structurally defined signaling in neuro-glia units in the enteric nervous system. Glia 67 (6): 1167–1178. https://doi.org/10.1002/glia.23596.CrossRefPubMedPubMedCentral

Cheadle, G.A., T.W. Costantini, N. Lopez, V. Bansal, B.P. Eliceiri, and R. Coimbra. 2013. Enteric glia cells attenuate cytomix-induced intestinal epithelial barrier breakdown. PLoS ONE 8 (7): e69042. https://doi.org/10.1371/journal.pone.0069042.CrossRefPubMedPubMedCentral

Langness, S., M. Kojima, R. Coimbra, B.P. Eliceiri, and T.W. Costantini. 2017. Enteric glia cells are critical to limiting the intestinal inflammatory response after injury. American Journal of Physiology. Gastrointestinal and Liver Physiology 312 (3): G274–G282. https://doi.org/10.1152/ajpgi.00371.2016.CrossRefPubMed

Bush, T.G., T.C. Savidge, T.C. Freeman, H.J. Cox, E.A. Campbell, L. Mucke, M.H. Johnson, and M.V. Sofroniew. 1998. Fulminant jejuno-ileitis following ablation of enteric glia in adult transgenic mice. Cell 93 (2): 189–201. https://doi.org/10.1016/s0092-8674(00)81571-8.CrossRefPubMed

Van Landeghem, L., J. Chevalier, M.M. Mahe, T. Wedel, P. Urvil, P. Derkinderen, T. Savidge, and M. Neunlist. 2011. Enteric glia promote intestinal mucosal healing via activation of focal adhesion kinase and release of proEGF. American Journal of Physiology. Gastrointestinal and Liver Physiology 300 (6): G976-987. https://doi.org/10.1152/ajpgi.00427.2010.CrossRefPubMedPubMedCentral

10.

Li, Y., Y. Ge, W. Zhu, J. Gong, L. Cao, Z. Guo, L. Gu, and J. Li. 2018. Increased enteric glial cells in proximal margin of resection is associated with postoperative recurrence of Crohn’s disease. Journal of Gastroenterology and Hepatology 33 (3): 638–644. https://doi.org/10.1111/jgh.13973.CrossRefPubMed

11.

da Silveira, A.B., E.C. de Oliveira, S.G. Neto, A.O. Luquetti, R.T. Fujiwara, R.C. Oliveira, and A. Brehmer. 2011. Enteroglial cells act as antigen-presenting cells in chagasic megacolon. Human Pathology 42 (4): 522–532. https://doi.org/10.1016/j.humpath.2010.06.016.CrossRefPubMed

12.

Kermarrec, L., T. Durand, M. Neunlist, P. Naveilhan, and I. Neveu. 2016. Enteric glial cells have specific immunosuppressive properties. Journal of Neuroimmunology 295–296: 79–83. https://doi.org/10.1016/j.jneuroim.2016.04.011.CrossRefPubMed

13.

Kermarrec, L., T. Durand, J. Gonzales, J. Pabois, P. Hulin, M. Neunlist, I. Neveu, and P. Naveilhan. 2019. Rat enteric glial cells express novel isoforms of Interleukine-7 regulated during inflammation. Neurogastroenterology and Motility 31 (1): e13467. https://doi.org/10.1111/nmo.13467.CrossRefPubMed

14.

Watson, V.E., M.E. Jacob, J.R. Flowers, S.J. Strong, C. DebRoy, and J.L. Gookin. 2017. Association of atypical enteropathogenic Escherichia coli with diarrhea and related mortality in kittens. Journal of Clinical Microbiology 55 (9): 2719–2735. https://doi.org/10.1128/JCM.00403-17.CrossRefPubMedPubMedCentral

15.

Tan, H., J. Zhao, H. Zhang, Q. Zhai, and W. Chen. 2019. Novel strains of Bacteroides fragilis and Bacteroides ovatus alleviate the LPS-induced inflammation in mice. Applied Microbiology and Biotechnology 103 (5): 2353–2365. https://doi.org/10.1007/s00253-019-09617-1.CrossRefPubMed

16.

Ahmadi Badi, S., S.H. Khatami, S.H. Irani, and S.D. Siadat. 2019. induction effects of bacteroides fragilis derived outer membrane vesicles on toll like receptor 2, toll like receptor 4 genes expression and cytokines concentration in human intestinal epithelial cells. Cell Journal 21 (1): 57–61. https://doi.org/10.22074/cellj.2019.5750.CrossRefPubMed

17.

Trejo, F.M., G.L. De Antoni, and P.F. Perez. 2013. Protective effect of bifidobacteria in an experimental model of Clostridium difficile associated colitis. Journal of Dairy Research 80 (3): 263–269. https://doi.org/10.1017/S0022029913000216.CrossRefPubMed

18.

Culpepper, T., M.C. Christman, C. Nieves Jr., G.J. Specht, C.C. Rowe, S.J. Spaiser, A.L. Ford, W.J. Dahl, S.A. Girard, and B. Langkamp-Henken. 2016. Bifidobacterium bifidum R0071 decreases stress-associated diarrhoea-related symptoms and self-reported stress: A secondary analysis of a randomised trial. Benef Microbes 7 (3): 327–336. https://doi.org/10.3920/BM2015.0156.CrossRefPubMed

19.

Compare, D., A. Rocco, P. Coccoli, D. Angrisani, C. Sgamato, B. Iovine, U. Salvatore, and G. Nardone. 2017. Lactobacillus casei DG and its postbiotic reduce the inflammatory mucosal response: An ex-vivo organ culture model of post-infectious irritable bowel syndrome. BMC Gastroenterology 17 (1): 53. https://doi.org/10.1186/s12876-017-0605-x.CrossRefPubMedPubMedCentral

20.

Yoon, J.S., W. Sohn, O.Y. Lee, S.P. Lee, K.N. Lee, D.W. Jun, H.L. Lee, et al. 2014. Effect of multispecies probiotics on irritable bowel syndrome: A randomized, double-blind, placebo-controlled trial. Journal of Gastroenterology and Hepatology 29 (1): 52–59. https://doi.org/10.1111/jgh.12322.CrossRefPubMed

21.

Ki Cha, B., S. Mun Jung, C. Hwan Choi, I.D. Song, H. Woong Lee, H. Joon Kim, J. Hyuk, et al. 2012. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: A randomized, double-blind, placebo-controlled trial. Journal of Clinical Gastroenterology 46 (3): 220–227. https://doi.org/10.1097/MCG.0b013e31823712b1.CrossRefPubMed

22.

Panpetch, W., P. Hiengrach, S. Nilgate, S. Tumwasorn, N. Somboonna, A. Wilantho, P. Chatthanathon, P. Prueksapanich, and A. Leelahavanichkul. 2019. Additional Candida albicans administration enhances the severity of dextran sulfate solution induced colitis mouse model through leaky gut-enhanced systemic inflammation and gut-dysbiosis but attenuated by Lactobacillus rhamnosus L34. Gut Microbes:1–16. https://doi.org/10.1080/19490976.2019.1662712.

23.

Stofilova, J., T. Langerholc, C. Botta, P. Treven, L. Gradisnik, R. Salaj, A. Soltesova, I. Bertkova, Z. Hertelyova, and A. Bomba. 2017. Cytokine production in vitro and in rat model of colitis in response to Lactobacillus plantarum LS/07. Biomedicine & Pharmacotherapy 94: 1176–1185. https://doi.org/10.1016/j.biopha.2017.07.138.CrossRef

24.

Schutze, S., S. Ribes, A. Kaufmann, A. Manig, J. Scheffel, S. Redlich, S. Bunkowski, U. K. Hanisch, W. Bruck, and R. Nau. 2014. Higher mortality and impaired elimination of bacteria in aged mice after intracerebral infection with E. coli are associated with an age-related decline of microglia and macrophage functions. Oncotarget 5 (24):12573–12592. https://doi.org/10.18632/oncotarget.2709.

25.

Puntener, U., S.G. Booth, V.H. Perry, and J.L. Teeling. 2012. Long-term impact of systemic bacterial infection on the cerebral vasculature and microglia. Journal of Neuroinflammation 9: 146. https://doi.org/10.1186/1742-2094-9-146.CrossRefPubMedPubMedCentral

26.

Pavanelli, M.F., C.M. Colli, R.C. Bezagio, M.B. Gois, G. de Alcantara Nogueira, E.J. de Melo, and de Almeida Araujo, and D. de Mello Goncales Sant’Ana. 2018. Assemblages A and B of Giardia duodenalis reduce enteric glial cells in the small intestine in mice. Parasitology Research 117 (7): 2025–2033. https://doi.org/10.1007/s00436-018-5853-3.CrossRefPubMed

27.

Pochard, C., S. Coquenlorge, M. Freyssinet, P. Naveilhan, A. Bourreille, M. Neunlist, and M. Rolli-Derkinderen. 2018. The multiple faces of inflammatory enteric glial cells: Is Crohn’s disease a gliopathy? American Journal of Physiology. Gastrointestinal and Liver Physiology 315 (1): G1–G11. https://doi.org/10.1152/ajpgi.00016.2018.CrossRefPubMed

28.

Bassotti, G., L. Macchioni, L. Corazzi, P. Marconi, and K. Fettucciari. 2018. Clostridium difficile-related postinfectious IBS: A case of enteroglial microbiological stalking and/or the solution of a conundrum? Cellular and Molecular Life Sciences 75 (7): 1145–1149. https://doi.org/10.1007/s00018-017-2736-1.CrossRefPubMed

29.

Gardner, J.K., S.M.J. Cornwall, A.W. Musk, J. Alvarez, C.D.S. Mamotte, C. Jackaman, A.K. Nowak, and D.J. Nelson. 2018. Elderly dendritic cells respond to LPS/IFN-gamma and CD40L stimulation despite incomplete maturation. PLoS ONE 13 (4): e0195313. https://doi.org/10.1371/journal.pone.0195313.CrossRefPubMedPubMedCentral

30.

Cirillo, C., G. Sarnelli, F. Turco, A. Mango, M. Grosso, G. Aprea, S. Masone, and R. Cuomo. 2011. Proinflammatory stimuli activates human-derived enteroglial cells and induces autocrine nitric oxide production. Neurogastroenterology and Motility 23 (9): e372-382. https://doi.org/10.1111/j.1365-2982.2011.01748.x.CrossRefPubMed

31.

Turco, F., G. Sarnelli, C. Cirillo, I. Palumbo, F. De Giorgi, A. D’Alessandro, M. Cammarota, M. Giuliano, and R. Cuomo. 2014. Enteroglial-derived S100B protein integrates bacteria-induced toll-like receptor signalling in human enteric glial cells. Gut 63 (1): 105–115. https://doi.org/10.1136/gutjnl-2012-302090.CrossRefPubMed

32.

Li, X., X. Zhang, P. Gong, F. Xia, L. Li, Z. Yang, and J. Li. 2017. TLR2(-/-) Mice display decreased severity of giardiasis via enhanced proinflammatory cytokines production dependent on AKT signal pathway. Frontiers in Immunology 8: 1186. https://doi.org/10.3389/fimmu.2017.01186.CrossRefPubMedPubMedCentral

33.

Jia, Y.P., K. Wang, Z.J. Zhang, Y.N. Tong, D. Han, C.Y. Hu, Q. Li, Y. Xiang, X.H. Mao, and B. Tang. 2017. TLR2/TLR4 activation induces Tregs and suppresses intestinal inflammation caused by Fusobacterium nucleatum in vivo. PLoS ONE 12 (10): e0186179. https://doi.org/10.1371/journal.pone.0186179.CrossRefPubMedPubMedCentral

34.

Hoang, T.K., B. He, T. Wang, D.Q. Tran, J.M. Rhoads, and Y. Liu. 2018. Protective effect of Lactobacillus reuteri DSM 17938 against experimental necrotizing enterocolitis is mediated by toll-like receptor 2. American Journal of Physiology. Gastrointestinal and Liver Physiology 315 (2): G231–G240. https://doi.org/10.1152/ajpgi.00084.2017.CrossRefPubMedPubMedCentral

35.

Brun, P., S. Gobbo, V. Caputi, L. Spagnol, G. Schirato, M. Pasqualin, E. Levorato, G. Palu, M.C. Giron, and I. Castagliuolo. 2015. Toll like receptor-2 regulates production of glial-derived neurotrophic factors in murine intestinal smooth muscle cells. Molecular and Cellular Neuroscience 68: 24–35. https://doi.org/10.1016/j.mcn.2015.03.018.CrossRefPubMed

36.

Liu, G.X., Y.X. Yang, J. Yan, T. Zhang, Y.P. Zou, X.L. Huang, and H.T. Gan. 2014. Glial-derived neurotrophic factor reduces inflammation and improves delayed colonic transit in rat models of dextran sulfate sodium-induced colitis. International Immunopharmacology 19 (1): 145–152. https://doi.org/10.1016/j.intimp.2014.01.008.CrossRefPubMed

37.

Bauman, B.D., J. Meng, L. Zhang, A. Louiselle, E. Zheng, S. Banerjee, S. Roy, and B.J. Segura. 2017. Enteric glial-mediated enhancement of intestinal barrier integrity is compromised by morphine. Journal of Surgical Research 219: 214–221. https://doi.org/10.1016/j.jss.2017.05.099.CrossRefPubMed

38.

Underwood, M. A., J. Arriola, C. W. Gerber, A. Kaveti, K. M. Kalanetra, A. Kananurak, C. L. Bevins, D. A. Mills, and B. Dvorak. 2014. Bifidobacterium longum subsp. infantis in experimental necrotizing enterocolitis: alterations in inflammation, innate immune response, and the microbiota. Pediatr Res 76 (4):326–333. https://doi.org/10.1038/pr.2014.102.

39.

Lopez, P., I. Gonzalez-Rodriguez, B. Sanchez, M. Gueimonde, A. Margolles, and A. Suarez. 2012. Treg-inducing membrane vesicles from Bifidobacterium bifidum LMG13195 as potential adjuvants in immunotherapy. Vaccine 30 (5): 825–829. https://doi.org/10.1016/j.vaccine.2011.11.115.CrossRefPubMed

40.

Lopez, P., I. Gonzalez-Rodriguez, B. Sanchez, P. Ruas-Madiedo, A. Suarez, A. Margolles, and M. Gueimonde. 2012. Interaction of Bifidobacterium bifidum LMG13195 with HT29 cells influences regulatory-T-cell-associated chemokine receptor expression. Applied and Environment Microbiology 78 (8): 2850–2857. https://doi.org/10.1128/AEM.07581-11.CrossRef

41.

Yang, X., X.C. Gao, J. Liu, and H.Y. Ren. 2017. Effect of EPEC endotoxin and bifidobacteria on intestinal barrier function through modulation of toll-like receptor 2 and toll-like receptor 4 expression in intestinal epithelial cell-18. World Journal of Gastroenterology 23 (26): 4744–4751. https://doi.org/10.3748/wjg.v23.i26.4744.CrossRefPubMedPubMedCentral

42.

Telesford, K.M., W. Yan, J. Ochoa-Reparaz, A. Pant, C. Kircher, M.A. Christy, S. Begum-Haque, D.L. Kasper, and L.H. Kasper. 2015. A commensal symbiotic factor derived from Bacteroides fragilis promotes human CD39(+)Foxp3(+) T cells and Treg function. Gut Microbes 6 (4): 234–242. https://doi.org/10.1080/19490976.2015.1056973.CrossRefPubMedPubMedCentral

43.

Weiss, G., S. Rasmussen, L.H. Zeuthen, B.N. Nielsen, H. Jarmer, L. Jespersen, and H. Frokiaer. 2010. Lactobacillus acidophilus induces virus immune defence genes in murine dendritic cells by a Toll-like receptor-2-dependent mechanism. Immunology 131 (2): 268–281. https://doi.org/10.1111/j.1365-2567.2010.03301.x.CrossRefPubMedPubMedCentral

44.

Alhawi, M., J. Stewart, C. Erridge, S. Patrick, and I.R. Poxton. 2009. Bacteroides fragilis signals through Toll-like receptor (TLR) 2 and not through TLR4. Journal of Medical Microbiology 58 (Pt 8): 1015–1022. https://doi.org/10.1099/jmm.0.009936-0.CrossRefPubMed

45.

Zhang, D.K., F.Q. He, T.K. Li, X.H. Pang, D.J. Cui, Q. Xie, X.L. Huang, and H.T. Gan. 2010. Glial-derived neurotrophic factor regulates intestinal epithelial barrier function and inflammation and is therapeutic for murine colitis. The Journal of Pathology 222 (2): 213–222. https://doi.org/10.1002/path.2749.CrossRefPubMed

46.

Ermolenko, E., O. Rybalchenko, Y. Borshev, E. Tarasova, T. Kramskaya, G. Leontieva, M. Kotyleva, O. Orlova, I. Abdurasulova, and A. Suvorov. 2018. Influence of monostrain and multistrain probiotics on immunity, intestinal ultrastructure and microbiota in experimental dysbiosis. Benef Microbes 9 (6): 937–949. https://doi.org/10.3920/BM2017.0117.CrossRefPubMed

47.

Hong, K.B., H. Seo, J.S. Lee, and Y. Park. 2019. Effects of probiotic supplementation on post-infectious irritable bowel syndrome in rodent model. BMC Complementary and Alternative Medicine 19 (1): 195. https://doi.org/10.1186/s12906-019-2610-9.CrossRefPubMedPubMedCentral

48.

Zaylaa, M., J. Alard, I.A. Kassaa, V. Peucelle, D. Boutillier, J. Desramaut, P. Rosenstiel, et al. 2019. Autophagy: A novel mechanism involved in the anti-inflammatory abilities of probiotics. Cellular Physiology and Biochemistry 53 (5): 774–793. https://doi.org/10.33594/000000172.CrossRefPubMed

49.

Tenore, S.B., V.I. Avelino-Silva, P.R. Costa, L.M. Franco, E.C. Sabino, J. Kalil, N.B. Cerqueira, Z. Nakagawa, and E.G. Kallas. 2020. Immune effects of Lactobacillus casei Shirota in treated HIV-infected patients with poor CD4+ T-cell recovery. AIDS 34 (3): 381–389. https://doi.org/10.1097/QAD.0000000000002420.CrossRefPubMed

Titel: Bifidobacterium bifidum and Bacteroides fragilis Induced Differential Immune Regulation of Enteric Glial Cells Subjected to Exogenous Inflammatory Stimulation
verfasst von: Yan-hua Yang
Wei Qian
Xiao-hua Hou
Chi-bing Dai
Publikationsdatum: 01.07.2022
Verlag: Springer US
Erschienen in: Inflammation / Ausgabe 6/2022
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI: https://doi.org/10.1007/s10753-022-01700-6

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Bifidobacterium bifidum and Bacteroides fragilis Induced Differential Immune Regulation of Enteric Glial Cells Subjected to Exogenous Inflammatory Stimulation

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

15% bedauern gewählte Blasenkrebs-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Update Innere Medizin

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2022

Melatonin Alleviates Ovariectomy-Induced Cardiovascular Inflammation in Sedentary or Exercised Rats by Upregulating SIRT1

Modulation of Microglia M2 Polarization and Alleviation of Hippocampal Neuron Injury By MiR-106b-5p/RGMa in a Mouse Model of Status Epilepticus

Morin Inhibits Dox-Induced Vascular Inflammation By Regulating PTEN/AKT/NF-κB Pathway

Therapeutic Potential of Curcumin in a Rat Model of Dextran Sulfate Sodium–Induced Ulcerative Colitis by Regulating the Balance of Treg/Th17 Cells

Fenofibrate Downregulates NF-κB Signaling to Inhibit Pro-inflammatory Cytokine Secretion in Human THP-1 Macrophages and During Primary Biliary Cholangitis

Aging Promotes Chronic Stress-Induced Depressive-Like Behavior by Activating NLRP1 Inflammasome-Driven Inflammatory Signaling in Mice

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

15% bedauern gewählte Blasenkrebs-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Update Innere Medizin